Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Ucb Pharma Aktiebolag (Sweden)
AB
Active
Org 5560711185
Olof Palmes Gata 29, 111 22
Stockholm
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 1960
20-49 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ucb Pharma Aktiebolag (Sweden)
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PB
Patric Berling
Chief Executive Officer
Chief Executive Officer
2020
SD
Samuel Douglas Bjälkemo
Chief Auditor
Chief Auditor
2022
Former (4)
PO
Per Ove Jonas Berg
Chief Executive Officer
Chief Executive Officer
2020 – 2020
PJ
Patrik John Martin Larsson
Chief Auditor
Chief Auditor
2021 – 2022
LA
Lars Anders Carlsson
Auditor Substitute
Auditor Substitute
2020 – 2022
CJ
Christer Jan-Erik Kilefors
Audit
Audit
2020 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
JM
Jaana Mattila
Board of Directors
2025
CJ
Christina Jeppesen
Board of Directors
2025
LA
Laura Ann Byram
Chairman
2025
Former (4)
AR
Afshin Risseh
Board of Directors
2020 – 2025
IV
Ilaria Villa
Chairman
2020 – 2022
AI
Ana Isabel Infante Gonzales De La Aleja
Chairman
2022 – 2025
WC
Willy Constant Cnops
Chairman
2020 – 2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
UCB PHARMA SA
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Ucb Pharma Aktiebolag (Sweden)
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
